Bone Marrow TransplantationHepatic Veno-Occlusive DiseaseTransplantation, HomologousGraft vs Host DiseaseWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsTransplantation, AutologousT-LymphocytesGraft SurvivalMice, Inbred C57BLKidney TransplantationHematopoietic Stem CellsGraft RejectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone and BonesLiver TransplantationImmunosuppressive AgentsTransplantation ChimeraTime FactorsTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingCyclosporineHistocompatibilityTransplantation, IsogeneicImmunosuppressionCyclophosphamideBone Marrow DiseasesHematopoiesisRecurrenceRadiation ChimeraCombined Modality TherapyTreatment OutcomeChronic DiseaseRetrospective StudiesLeukemia, Myeloid, AcuteBone Marrow ExaminationHematologic NeoplasmsTransplantation ImmunologyRemission InductionRats, Inbred LewGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingLymphocyte DepletionBone Marrow NeoplasmsHeart TransplantationStem Cell TransplantationLeukemia, MyeloidSevere Combined ImmunodeficiencyAcute DiseaseLeukocyte TransfusionLymphoma, Non-HodgkinPostoperative ComplicationsChimeraColony-Forming Units AssayHLA AntigensSurvival AnalysisLung TransplantationMyelodysplastic SyndromesLymphocyte TransfusionHematologic DiseasesBone DensityActuarial AnalysisFollow-Up StudiesCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyOrgan TransplantationCarmustineGraft vs Tumor EffectGraft vs Leukemia EffectSurvival RateCytomegalovirus InfectionsSpleenPancytopeniaLeukocyte CountKidney DiseasesMice, Inbred BALB CCytarabineGranulocyte Colony-Stimulating FactorFlow CytometryBone ResorptionMelphalanCells, CulturedDisease-Free SurvivalEtoposideLymphomaKidneyMice, KnockoutMultiple MyelomaAntigens, CD34Thymus GlandCell Transplantation